Technology-driven isotopic labeling in API development
Isotopic labeling of APIs is becoming more challenging, particularly for complex targeted therapies.
The application of biocatalytic tools can introduce complex functionality in a single step and reduce the cost of developing labeled biomolecules and chiral compounds.